David Rosenthal M.d.

David Rosenthal M.D. is a multifaceted professional with extensive experience in healthcare investment, advisory roles, and academic contributions. Currently serving as an Angel Investor at Cellsbin and AvoMD, and involved with various companies as an advisor and investor, Rosenthal has a keen focus on healthcare innovations intersecting therapeutics, diagnostics, and technology, particularly in AI and data science. As a Healthcare Venture Partner at AlleyCorp, Rosenthal supports early-stage companies in the Greater New York Metropolitan Area. In academia, Rosenthal holds a position as an Assistant Professor at Yale School of Medicine, where responsibilities include clinical practice and course leadership. Rosenthal is also an Aspen Health Innovators Fellow, aiming to enhance leadership in the U.S. healthcare ecosystem. With a solid educational background from Harvard University and Northwestern University, Rosenthal combines expertise in medicine and business to drive impactful healthcare solutions.